` 5 "

: Xeljanz 5 Mg. ?  »
|
-

PER OS

Tablets

Inhibitor of Janus kinases (JAKs), is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to methotrexate. It may be used as monotherapy or in combination with methotrexate or other nonbiologic disease-modifying antirheumatic drugs (DMARDs).XELJANZ should not be used in combination with biologic DMARDs or with potent immunosuppressants such as azathioprine and cyclosporine.

152 35 33973 01

Pfizer Manufacturing Deutschland Gmbh, Germany

07/2014 - 06/2019

.
, .
.
/
Tofacitinib 5 MG
Bottle hdpe 60 x TABLETS 24
Bottle hdpe 180 x TABLETS 24
Bottle hdpe 28 x TABLETS 24

*

*

 

.

 
" !
 
278
,